Correlation Between Adicet Bio and C4 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Adicet Bio and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adicet Bio and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adicet Bio and C4 Therapeutics, you can compare the effects of market volatilities on Adicet Bio and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adicet Bio with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adicet Bio and C4 Therapeutics.
Diversification Opportunities for Adicet Bio and C4 Therapeutics
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Adicet and CCCC is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Adicet Bio and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Adicet Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adicet Bio are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Adicet Bio i.e., Adicet Bio and C4 Therapeutics go up and down completely randomly.
Pair Corralation between Adicet Bio and C4 Therapeutics
Given the investment horizon of 90 days Adicet Bio is expected to under-perform the C4 Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Adicet Bio is 1.23 times less risky than C4 Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The C4 Therapeutics is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 601.00 in C4 Therapeutics on September 2, 2024 and sell it today you would lose (146.00) from holding C4 Therapeutics or give up 24.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adicet Bio vs. C4 Therapeutics
Performance |
| Timeline |
| Adicet Bio |
| C4 Therapeutics |
Adicet Bio and C4 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adicet Bio and C4 Therapeutics
The main advantage of trading using opposite Adicet Bio and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adicet Bio position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.| Adicet Bio vs. Edgewise Therapeutics | Adicet Bio vs. Cullinan Oncology LLC | Adicet Bio vs. Vor Biopharma | Adicet Bio vs. Tenaya Therapeutics |
| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stocks Directory Find actively traded stocks across global markets |